Skip to content
LexBuild

Request for Information-Pandemic and All-Hazards Preparedness and Advancing Innovation Act Section 209; Extension of Comment Period

---
identifier: "/us/fr/2020-07442"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Request for Information-Pandemic and All-Hazards Preparedness and Advancing Innovation Act Section 209; Extension of Comment Period"
title_number: 0
title_name: "Federal Register"
section_number: "2020-07442"
section_name: "Request for Information-Pandemic and All-Hazards Preparedness and Advancing Innovation Act Section 209; Extension of Comment Period"
positive_law: false
currency: "2020-04-09"
last_updated: "2020-04-09"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "2020-07442"
document_type: "notice"
publication_date: "2020-04-09"
agencies:
  - "Health and Human Services Department"
fr_citation: "85 FR 19950"
fr_volume: 85
comments_close_date: "2020-06-21"
fr_action: "Notice; extension of comment period."
---

#  Request for Information—Pandemic and All-Hazards Preparedness and Advancing Innovation Act Section 209; Extension of Comment Period

**AGENCY:**

Office of Infectious Disease and HIV/AIDS Policy, Office of the Assistant Secretary for Health, Office of the Secretary, Department of Health and Human Services.

**ACTION:**

Notice; extension of comment period.

**SUMMARY:**

The Office of the Assistant Secretary for Health published a document in the *Federal Register* of March 23, 2020 requesting public comment related to Section 209 of the Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Due to requests of an extension to the public comment period, this document is announcing an extension.

**DATES:**

To be assured consideration, comments must be received at the address provided below no later than midnight Eastern Standard Time (EST) on June 21, 2020.

**FOR FURTHER INFORMATION CONTACT:**

Mr. James Berger, (202) 795-7608; *[email protected].*

Dated: April 3, 2020.

James J. Berger,

Senior Advisor for Blood and Tissue Policy, Office of the Assistant Secretary for Health.